Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RABEPRAZOLE vs RALOXIFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RABEPRAZOLE vs RALOXIFENE: Safety Overview

Metric RABEPRAZOLE RALOXIFENE
Total FAERS Reports 11,416 4,185
Deaths Reported 1,676 34
Death Rate 14.7% 0.8%
Hospitalizations 2,143 346
Average Patient Age 55.7 yrs 67.7 yrs
% Female Patients 71.0% 99.7%
FDA Approval Date Apr 24, 2018 Apr 8, 2016
Manufacturer A-S Medication Solutions American Health Packaging
Route ORAL ORAL
Marketing Status Discontinued Prescription